Study of a combination pill for high cholesterol
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests a single pill that combines two cholesterol-lowering medicines (pitavastatin and ezetimibe). It may be a good fit if you already take a statin or a statin plus ezetimibe and your doctor wants to adjust your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently taking a statin or a statin plus ezetimibe (Zetia) for high cholesterol.
- Your doctor has decided you need to change your statin dose, switch to a different statin, or add ezetimibe.
- You are not already taking a combination pill of pitavastatin and ezetimibe.
- You have no known allergy to pitavastatin (Livalo) or ezetimibe (Zetia).
- You have not been in another research study for an investigational drug in the last 12 weeks, and you won't join another study during this one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes patients with high cholesterol or mixed lipid disorders who are taking bempedoic acid, alone or with ezetimibe, to see how it works in real life. It aims to gather information that may help doctors better manage cholesterol.
This trial tests a new medicine called EDP167 for adults with mixed dyslipidemia, a condition of high cholesterol and triglycerides. It aims to see if the drug lowers lipids more than current treatments and how safe it is.
This trial tests a combination pill of two cholesterol-lowering medicines (pitavastatin and ezetimibe) in adults who have been taking either atorvastatin or rosuvastatin for at least 3 months. It aims to see if switching to this new combination is safe and effective.
This study watches how well a combination cholesterol medication (pitavastatin and ezetimibe) works in people who have high cholesterol and metabolic syndrome (a cluster of health issues including high blood pressure, blood sugar, and cholesterol). You'll be monitored over time to see if the medication helps and is safe for you.
This trial compares two cholesterol-lowering treatment plans after a heart procedure where new drug-eluting stents were placed: a combination of high-intensity statin plus ezetimibe versus high-intensity statin alone. It may help find which option lowers cholesterol more effectively and safely over the first year after the procedure.
This trial compares a lower-dose cholesterol pill (rosuvastatin plus ezetimibe) to a higher-dose version of just rosuvastatin for people with mild to moderate heart artery blockages who have not had a stent or bypass. It aims to see which approach works better and is safer.
Hear when a new Primary Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.